Table 1.
Demographic, clinical, and inflammatory characteristics of patients with asthma
| Characteristic | |
|---|---|
| N | 232 |
| Age, years | |
| ≤ 20 | 8 (3.4%) |
| 21–40 | 39 (16.8%) |
| 41–60 | 129 (55.6%) |
| 61–80 | 56 (24.1%) |
| Sex (M/F) | 109/123 |
| Height, cm | 166 ± 7.9 |
| Weight, kg | 65 ± 11.2 |
| Never smoker, N (%) | 133 (57.3%) |
| Ex-smokers (n) (pack-years) | 50 (16 (5.2, 16.0)) |
| Current smokers (n) (pack-years) | 49 (22 (13.0, 37.3)) |
| Diagnosis age (y) | 45 ± 15 |
| Total controlled, N (%) | 70 (30.2%) |
| Partial controlled, N (%) | 60 (25.9%) |
| Severe asthma, N (%) | 89 (38.4%) |
| Atopy (Y/N) | 37/80 |
| ACO, N (%) | 118 (50.8%) |
| Triggering factors (Y/N) | 200/32 |
| Seasons, N (%) | 114 (49.1%) |
| Exercise, N (%) | 101 (43.5%) |
| URTI, N (%) | 141 (60.7%) |
| Work, N (%) | 20 (8.6%) |
| Gastroesophageal reflux, N (%) | 14 (6.0%) |
| Pets, N (%) | 11 (4.7%) |
| Food, N (%) | 20 (8.6%) |
| Aspirin, N (%) | 6 (2.6%) |
| Fumes, N (%) | 50 (21.6%) |
| Rhinitis, N (%) | 78 (33.6%) |
| Post-FEV1/FVC, % | 67.9 ± 13.0 |
| Post-FEV1% predicted | 84.8 (63.9, 97.6) |
| FeNO (ppd) | 40.9 (23.1, 77.8) |
| Application of ICS/(ICS + LABA) in the past year (Y/N) | 112/120 |
| ≤ 3 month, N (%) | 39 (16.8%) |
| 3–6 month, N (%) | 21 (9.1%) |
| > 6 month, N (%) | 52 (22.4%) |
Data are presented as mean ± SD or median (IQR), unless otherwise indicated
ACO Asthma-COPD overlap, URTI upper respiratory tract infection, FeNO fractional exhaled nitric oxide, TCC total cell count, IQR interquartile range